News
thumbnail
Facilities & CapacityAstraZeneca bolsters CGT ambitions through $300m expansionAstraZeneca bolsters CGT ambitions through $300m expansion
Buttressing its footing in the cell and gene therapy (CGT) space, AstraZeneca has invested $300 million in an 84,000 square-foot facility in Maryland.